<?xml version="1.0" encoding="utf-8" standalone="yes"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Thomas Ried on Genetics Branch Retreat</title>
    <link>https://seandavi.github.io/genetics_branch_retreat_site/tags/thomas-ried/</link>
    <description>Recent content in Thomas Ried on Genetics Branch Retreat</description>
    <generator>Hugo -- gohugo.io</generator>
    <language>en-us</language>
    
	<atom:link href="https://seandavi.github.io/genetics_branch_retreat_site/tags/thomas-ried/index.xml" rel="self" type="application/rss+xml" />
    
    
    <item>
      <title>Genomic Heterogeneity and Clonal Dynamics of the Evolution of Treatment Resistance and Metastatic Progression in Rectal Cancer</title>
      <link>https://seandavi.github.io/genetics_branch_retreat_site/abstract/submission-4/</link>
      <pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate>
      
      <guid>https://seandavi.github.io/genetics_branch_retreat_site/abstract/submission-4/</guid>
      <description>Daniela Hirsch, Judith Lieberich, Kerstin Heselmeyer-Haddad, Yonca Ceribas, Michael Kelly, Keyur Talsania, Yongmei Zhao, Timo Gaiser, Thomas Ried
The standard treatment for locally advanced rectal cancer is chemoradiotherapy followed by surgery. However, patient response to pre-operative chemoradiotherapy is highly heterogeneous, ranging from complete tumor regression to no response. Over the course of disease, up to 40% of patients suffer from local relapse or the development of metachronous metastatic disease, compromising survival.</description>
    </item>
    
  </channel>
</rss>